🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 74065P101
- Market Cap
- Large Cap
- IPO
- 9/25/2020 · $19.00/share
Business: Prelude Therapeutics Inc. is a clinical-stage biopharmaceutical company designing and developing a pipeline of novel, orally bioavailable, small molecule therapies that target key drivers of cancer cell growth, survival and resistance.
Company Contact
- CEO
- Kris Vaddi
- CFO
- Brian Piper
- Headquarters
- 175 Innovation Boulevard, Wilmington, DE 19803
- Phone
- 302-467-1280
- Investor Relations
- Robert A. Doody · 212-600-1902 · prelude@argotpartners.com